“CENPF (+) cancer cells promote malignant progression of early-stage TP53 mutant lung adenocarcinoma” 🔵 Tao Jiang’s groundbreaking research appeared in #Oncogenesis ▶️ Read the full open access article here: www.nature.com/articles/s41...

“A dominant SRCAP truncating mutation promotes squamous cell carcinoma progression” 🔵 Xiaomin Bao latest and outstanding research is now available to read in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“RIOK3 sustains colorectal cancer cell survival under glucose deprivation via an HSP90α-dependent pathway” 🔵 Interesting research led by Shengtao Zhu has been featured in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“BRG1 inhibits glycolysis by promoting SHP1-mediated dephosphorylation of PKM2 in non-small cell lung cancer” 🔷 Haijie Li & Jingqin Lan latest research is now available to read in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

🔬 Oncogenesis at SA2M 2025 🔬 Oncogenesis was proud to support the Swiss Apoptosis & Autophagy Meeting (SA2M), held on 4–5 September 2025 at the Institute of Pathology, Inselspital, Bern and organized by Life Sciences Switzerland (LS2) - Autophagy

“Peroxisomal lipid metabolism inhibits Pimozide-induced cancer cell death by regulating ATP homeostasis” 🔷 Zhenye Yang latest research is now available to read in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

🧬Meet One of Our Associate Editors: Jerry Chipuk, PhD As a Professor of Oncological Sciences and Associate Director of the Tisch Cancer Institute at MS in NY, his research focuses on how mitochondria dictate fundamental cell biology, impact upon cancer mechanisms, and mediate therapeutic responses.

“Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse” 🔷 Outstanding research from J. Pannequin, W. Bourguet, M. Amblard & JM Pascussi is now available to read in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer” 🔷 High-impact research led by Atanasio Pandiellahas has been featured in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer” 🔷 Ramona Schulz-Heddergott latest research is now available to read in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Condensate remodeling reorganizes innate SS18 in synovial sarcomagenesis” ✨ Interesting findings from research led by Duanqing Pei has been featured in #Oncogenesis. ▶️Read the full open access article here: www.nature.com/articles/s41...

“Novel CDK2/CDK9 inhibitor fadraciclib targets cell survival and DNA damage pathways and synergizes with encorafenib in human colorectal cancer cells with BRAF(V600E)” Discover Frank A. Sinicrope's newest findings, now featured in #Oncogenesis Read the full article: www.nature.com/articles/s41...

“Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma” 🔷 Hui-Zhen Nie noteworthy study has been published in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma” 🔷 Thomas Michael & Marti Patrick Dorn latest research is now available to read in #Oncogenesis ▶️ Read the full open access article here: www.nature.com/articles/s41...

“YAP/TAZ interacts with RBM39 to confer resistance against indisulam” Groundbreaking research led by Mikihito Kajiya has been featured in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

'Collagen type IV alpha 6 promotes tumor progression and chemoresistance in ovarian cancer by activating the discoidin domain receptor 1 pathway' 🔷Soon-Cen Huang & Chou Cheng-Yang latest research is now available to read in #Oncogenesis ▶️ Read the full article here: www.nature.com/articles/s41...

“Involvement of Kindlin-1 in cutaneous squamous cell carcinoma” 🔷 Interesting research led by Valerie G. Brunton has been featured in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Targeting SLC7A5 in lung SC carcinoma: implications for cancer metabolism shift and boron neutron capture therapy resistance” 🔷 High-impact research led by Min-Yuan Chou & Yu-Ting Chou has been featured in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth” 🔵 Yanwei Luo’s groundbreaking research appeared in #Oncogenesis ▶️ Read the full open access article here: www.nature.com/articles/s41...

“GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells” 🔷 Jan Paul Medema latest research is now available to read in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells” 🔷 High-impact research led by Anna Woloszynska has been featured in #Oncogenesis. ▶️ Read the full open access article here: www.nature.com/articles/s41...

“Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2” 🔵‪Rendong Yang (@yang-lab.bsky.social)‬ & Qi Cao's latest research is now featured in #Oncogenesis! ▶️Read the full open access article here: www.nature.com/articles/s41...

🔵Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas Kim Rosalie Kampen’s groundbreaking research appeared in #Oncogenesis ▶️ Read the full open access article here: www.nature.com/articles/s41...

🔵 Dong-Joo Cheon latest research is now available to read in #Oncogenesis “Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistance” ▶️ Read the full open access article here: www.nature.com/articles/s41...

Groundbreaking research led by C. Arnold Spek has been featured in #Oncogenesis. “Identification of pancreatic cancer-specific protease substrates for protease-dependent targeted delivery” Read the full open access article here: www.nature.com/articles/s41...

Discover Min Li's newest findings, now featured in #Oncogenesis “CD147-high extracellular vesicles promote gastric cancer metastasis via VEGF/AKT/eNOS and AKT/mTOR pathways” Read the full open access article here: www.nature.com/articles/s41...

Richard G. Pestell’s impactful study has been published in #Oncogenesis “A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription” ▶️ Read the full open access article here: www.nature.com/articles/s41...

🔵 Jun Chen & Yang Song latest research is now available to read in #Oncogenesis “NUCKS1 promotes invasion and metastasis of colorectal cancer by stabilizing HDAC2 and activating AKT” ▶️ Read the full open access article here: www.nature.com/articles/s41...

Oncogenesis is proud to announce that our 2024 #ImpactFactor has increased to 6.4, placing us 50th out of 326 journals in #Oncology! 🏅 Top 50 Oncology Journal 📈 2024 Impact Factor: 6.4 We thank our authors, reviewers, and readers for their trust and contributions.

Discover Liat Drucker's newest findings, now featured in #Oncogenesis “Myeloma mesenchymal stem cells’ bioenergetics afford a novel selective therapeutic target” Read the full open access article here: lnkd.in/gB6Z2bws

Groundbreaking research led by Thomas Kietzmann has been featured in #Oncogenesis. “Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via INPP4B” Read the full open access article here: www.nature.com/articles/s41...

📣 Takehiko Kamijo latest research is now available to read in #Oncogenesis “Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma” ▶️ Read the full open access article here: lnkd.in/ea49FSa8

🔷 Xiaoping Wan & Wen Lu latest research is now available to read in #Oncogenesis “SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair” ▶️ Read the full open access article here: lnkd.in/e7hxgmqg

📣 Discover Casimiro Gerarduzzi's newest findings, now featured in hashtag#Oncogenesis! “FLT4 activation promotes acute lymphoid leukemia survival through stabilization of MDM2/MDMX and inactivation of p53” ▶️ Read the full open access article here: lnkd.in/e3fRdjb8

Groundbreaking research led by Giorgio Trinchieri and Curtis Harris has been featured in #Oncogenesis. “Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development” Read the full open access article here: www.nature.com/articles/s41...

Andreas Hecht latest research is now available to read in #Oncogenesis “TGF-β signaling redirects Sox11 gene regulatory activity to promote partial EMT and collective invasion of oncogenically transformed intestinal organoids” Read the full open access article here: www.nature.com/articles/s41...

Guro F. Giskeødegård’s recent study has been published in #Oncogenesis. “Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes” Read the full open access article here: www.nature.com/articles/s41...

⚠️The recent publication by Katherine Pillman, Greg Goodall and Cameron P. Bracken published in #Oncogenesis can redefine the field of microRNA research. “Chasing non-existent “microRNAs” in cancer” Read full open access article here: www.nature.com/articles/s41...

🔷 Groundbreaking research led by Mohieddin Jafari has been featured in #Oncogenesis. “Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling” ▶️ Read the full open access article here: lnkd.in/ejQQAn8J

Meet our Editor-in-Chief, Jean-Ehrland Ricci (@jer-06.bsky.social) As a Research Director at Inserm and head of the “metabolism, CAncer and immune REsponse” (mCARE) team at C3M, his research focuses on how metabolic pathways regulate cell death, immune responses, and therapy resistance in cancer.

📣 Welcome to the official Bluesky page of Oncogenesis! Oncogenesis is an open-access journal focused on the molecular basis of cancer and tumor development. Follow us to know more! 🔗 oncogenesisjournal.nature.com #CancerResearch #NaturePortfolio #Oncogenesis